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The Papanicolaou (Pap) smear is the most successful
screening test for carcinoma in the history of medicine.
Since its introduction in the early 1930s, the national death
rate from cervical cancer has dropped 70%.1 The success of
this test is mainly a result of its simplicity, low cost, and low
false-negative rate. The Pap test’s main benefit is the early
detection of preneoplastic lesions. The Pap test is also used
to diagnose several infectious agents that manifest with
specific cytologic features. Hormonal evaluation based on
smears of the lateral vaginal wall is another important use of
the Pap test.
The obstetric patient should receive a Pap smear at her
first prenatal visit as part of her initial evaluation. The
cytologic findings of those smears in this particular group of
women have been the subject of extensive research since the
1960s. This research has generally focused on the following
areas: 1) the ability to accurately diagnose preneoplastic
lesions during pregnancy in light of the numerous diagnostic
pitfalls that result from the physiologic changes that occur
during pregnancy;2,3 2) the use of hormonal evaluation and
maturity index to predict fetal status, e.g., maturation, sex,
placental activity, or an inevitable abortion;4–6 and 3) the
detection and significance of inflammation and infectious
agents.7–9
The incidence of squamous intraepithelial lesions (SIL) is
increasing among sexually active females, especially those
with sexually transmitted diseases (STD). In a study review-
ing 98 pregnant and postpartum patients with abnormal Pap
smears and directed biopsies, 67 were diagnosed with SIL.
Of these 67, 18 had high-grade (HG) SIL and 49 had
low-grade (LG) SIL.10 The most appropriate follow-up
strategy for pregnant women with abnormal cervical cytol-
ogy has also been the subject of extensive research. It is
well-documented that cervical dysplasia diagnosed during
pregnancy and followed by serial Pap smears until term may
not necessarily progress and on occasions may even re-
gress.11–13 Londo et al.14 found that postpartum Pap smears
provide a higher yield of endocervical cells and better
prediction of dysplasia than prepartum smears. Nonetheless,
this does not lessen the importance of the initial smear, since
a high number of these patients may be lost to follow-up
through noncompliance.11,14
Interpretation of Pap smears obtained from pregnant
patients can be difficult. Knowledge of the pitfalls unique to
pregnancy can minimize diagnostic errors in most cases.10
The most common pitfall is misinterpreting decidua cells for
SIL. Decidua cells may mimic LGSIL, HGSIL, and carci-
noma. Decidua cells that slough off the free surface of the
uterus may degenerate and acquire pyknotic nuclei and
orangeophilic cytoplasm and be mistaken for squamous-cell
carcinoma.15 During pregnancy, endocervical glands be-
come hyperplastic and hypertrophied, and may undergo
Aria-Stella-type changes. These changes are often overdiag-
nosed as atypical glandular cells of undetermined signifi-
cance.10,16 Even years after pregnancy, involuted decidua
and trophoblasts can mimic HGSIL and lead to inappropriate
treatment.17
Based on specific cytologic criteria, the diagnoses of
candida, trichomonas, herpes simplex virus, and human
papilloma virus can be reliably rendered on Pap smears.18
Although Clamydia trachomatisand gonococcal species
cannot be accurately diagnosed on Pap smears due to the
lack of specific cytologic features, they are frequently
associated with inflammatory exudate and reactive cellular
changes.19 Inflammation by itself on Pap smears is not
necessarily indicative of infection, and an inflammatory
component is commonly seen on Pap smears from pregnant
women.20,21 Unfortunately, the significance of a marked
inflammatory exudate in the pregnant population has not
been adequately evaluated. Since patients with sexually
transmitted diseases (STD) have a higher risk of preterm
delivery and fetal morbidity, it is important to evaluate
whether inflammation and/or the reactive changes caused by
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inflammation on Pap smears from pregnant patients can
reliably predict the presence of STD, particularly in asymp-
tomatic patients. In this issue, Bedrossian et al.22 ddress this
question by evaluating the significance of mucopurulent
exudate on Pap smears (inflammatory cells covering more
than 50% of the smear) in high-risk pregnant women. They
found these patients to be at high risk for STD and
pregnancy-related complications.
Bacterial vaginosis (BV) is a vaginal infection in which
the normal Lactobacillus-predominant vaginal flora is re-
placed byGardnerella vaginalis, Bacteroidesspecies,Mobi-
luncusspecies, and genital mycoplasma.23 BV and STD are
both risk factors for a complicated pregnancy. In this issue,
Mass et al.24 demonstrate a higher incidence of chorioamni-
onitis and preterm delivery in patients with coccobacilli and
clue cells on their initial Pap smears when compared to a
control group of similar women without these changes.
Gram stain and/or wet mount are traditionally the methods
of choice in diagnosing BV. While a wet mount is simple and
inexpensive, the literature suggests that poorly performed
wet mounts may result in misdiagnosis in about one third of
the cases.23 Using the Bethesda system (TBS), Pap smears
with BV are typically reported as ‘‘predominance of cocco-
bacilli consistent with shift in vaginal flora.’’ TBS falls short
of diagnosing BV, since the accuracy of this diagnosis by
Pap smear has been controversial, especially when com-
pared to the Gram stain.25–28 The limitations of the Pap
smear can be attributed to the following:28 1) the inconsis-
tency in the criteria used to diagnose BV, i.e., some studies
rely only on the presence of clue cells, while others adhere to
the criteria specified by TBS; 2) variation in specimen
source; studies evaluating vaginal smears report higher
sensitivity for BV than those evaluating cervical/endocervi-
cal smears; and 3) the experience and number of evaluators
differ among different studies and may contribute to the
variable reported sensitivity of the Pap smear when com-
pared to the Gram stain.
To improve Pap smear sensitivity in detecting BV, it is
important to further define the diagnostic features of this
condition. In this issue, Prey29 compares the ability to
diagnose BV by Pap smear based on TBS criteria vs. the
Gram stain. Her results reveal two important findings. First,
the diagnosis of BV by Pap smear requires the presence of
coccobacilli alone, not mixed with other bacterial flora.
Second, the Pap smear is at least as good as, if not superior
to, the Gram stain in identifying BV. She recommends
applying the strict criteria described by TBS. These criteria
are: 1) filmy background of small coccobacilli; 2) absence of
lactobacilli; and 3) individual squamous cells covered by a
layer of coccobacilli, particularly at the margin (clue cells).
In this age when cost efficiency seems so important, the
contribution of the Pap smear in the initial evaluation of
pregnant patients should be seriously considered. Since both
the Pap smear and Gram stain have close predictive values,
duplication of tests could reasonably be avoided in most
patients. Because BV is a vaginal rather than a cervical
infection, the addition of a well-performed vaginal compo-
nent to the routine cervical/endocervical smear in pregnant
women will improve Pap smear sensitivity. Cytotechnolo-
gists should be well-informed of the diagnostic criteria for a
shift in vaginal flora as outlined by TBS.
The Pap smear should be performed at the first prenatal
visit regardless of the duration of pregnancy to establish the
presence or absence of SIL, STD, and BV, all of which
represent a risk to the fetus and the mother. This initial smear
will not only establish a baseline at the first prenatal visit but
may also be the only opportunity to diagnose SIL in patients
with poor compliance. All these conditions can be followed
safely and accurately throughout pregnancy by repeated Pap
smears.
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